Transpek Industry Ltd

Meeting Details

• No analyst/investor meeting details provided in this filing chunk.

Business overview

• Chlorination chemistry and acid chlorides; diversified polymers and specialty chemicals.
• Expanding non-acid, non-alkyl chloride chemistries; Odisha land site under consideration.

Key operational highlights

• Q1 FY27 revenue from operations ₹151.1 crore.
• Q1 FY27 EBITDA ₹24.1 crore; PAT ₹8.9 crore.
• EBITDA margin 15.6%; PAT margin 5.8%.
• FY26 revenue ₹621.2 crore; EBITDA ₹117.9 crore; PAT ₹45.6 crore.
• New site options; Odisha land approval; Eurasia and South America customers.
• EcoVadis Gold award and Responsible Care certification.
• Capacity: multipurpose plants totaling 66,000 MTPA.
• R&D: DSIR-approved facility; plan to double R&D team.
• Geographic expansion to Eurasia and South America.

Financial performance

• Total revenue from operations (Q1 FY27) ₹155.1 crore.
• EBITDA (including Other Income) ₹24.1 crore.
• EBITDA margin 15.6% in Q1 FY27.
• PAT ₹8.9 crore; PAT margin 5.8%.
• FY26 revenue ₹645.7 crore; EBITDA ₹117.9 crore; PAT ₹45.6 crore.
• March-26: Total equity ₹767.4 crore; Total assets ₹1,008.3 crore.
• Net cash from operating activities ₹78.5 crore.
• Cash and cash equivalents ₹57.8 crore.
• Borrowings ₹42.5 crore (current ₹28.1 cr; non-current ₹14.4 cr).
• FY26 EBITDA margin 18.3%; EBIT margin 10.7%.

Capital structure & liquidity

• Debt position: total borrowings ₹42.5 crore; liquidity: cash ₹57.8 crore.
• Positive operating cash flow: ₹78.5 crore in Mar-26.

Strategic priorities & outlook

• Develop additional acid chlorides while advancing other products to commercialization in 2026-27.
• Geographic expansion; strengthening Eurasia and South America presence.
• R&D expansion; doubling team and infrastructure; sustainability initiatives.

Risks & mitigation

• Raw material price escalation (sulphur, chlorine) and higher freight costs.
• Transit time constraints and vessel availability; macro uncertainty from West Asia.
• Mitigation: innovation, geographic diversification, and portfolio expansion.

Governance & leadership

• Board chaired by Ashwin C. Shroff; MD is Bimal Mehta.
• Independent directors include Rita Teaotia and others.
• R&D facility recognized by Government of India.

Financial performance

• Revenue from operations: 62,119.90; down from 64,985.31 FY24-25
• PAT: 4,564.81; down 6.35% YoY
• EPS: ₹81.73 (basic and diluted)
• Export share: 83.10% of revenue
• Dividend per share: ₹20

Operations & capacity

• Installed capacity: 66,000 MTPA at Ekalbara
• Exports accounted for 83.1% of revenue in FY26
• Global presence across 16 countries; exports dominating revenue
• Three new non-acid chloride products under development
• Phased AI roadmap to enhance process control and efficiency

Capital structure & liquidity

• Borrowings: 4,245.54 Lakhs; Lease liabilities: 3,196.92 Lakhs
• Net debt: 7,442.46 Lakhs; Debt/Equity: 0.10
• Cash & cash equivalents: 5,783.11 Lakhs
• Capex: energy conservation ₹75 Lakhs; renewable energy investments
• No material liquidity concerns reported

ESG & sustainability

• EcoVadis Gold Medal; UN Global Compact; RSPO; Great Place to Work
• Scope 1/2/3 emissions: 192; 11,127; 89,557 tCO2e
• Water: 181,372 KL withdrawal; water intensity 0.0029 per turnover
• Waste: 2115.25 MT generated; 1174.10 MT recycled; 801.63 MT disposed
• FE11PL renewable energy 2.8 MW; commercialisation expected May 2026

Governance & risk

• Avtar Singh resigned 31 Mar 2026; MD transition underway
• Ashwin C. Shroff to be reappointed; Board to consider at AGM
• TNT & Associates appointed as Secretarial Auditor; no qualifications
• CSR Committee active; Risk Management Committee in place
• AGM details and governance disclosures updated

Dividends & AGM

• Dividend ₹20 per equity share; AGM 15 Sep 2026 via VC/OAVM
• DTAA options for non-residents; TDS guidelines clarified
• Notice and Annual Report sent electronically; no proxies allowed
• Tax compliance and share transfer arrangements explained in AGM notice
• Dividend tax payment and IEPF-related matters communicated

Outlook & risks

• 2025-26 faced volatility in crude prices and geopolitics; Western demand subdued
• FY2026-27 focus: product commercialization, geographic expansion, margin discipline
• AI and digitalisation to protect margins as scale increases
• Sustainability initiatives to maintain EcoVadis Gold status
• Management emphasizes disciplined cost control and resilient supply chains

Meeting Details

• Date/time: 20 August 2026, 4:00 PM IST
• Event: Business Update Call
• Type: group investor call; Mode: virtual

Participants

• Key participant: Managing Director

Purpose

• Discuss operational and financial performance

Additional Notes

• RSVP via Strategic Growth Advisors Pvt. Ltd.

Record date details

• Record date fixed as 7 September 2026 for final dividend on equity shares for FY25-26, subject to AGM.

AGM/EGM: No items disclosed in summary

Management change

• Dr. Gurpreet Kaur, Senior General Manager—R&D and QC, resigned for professional reasons, effective July 15, 2026.

Dematerialisation status

• Dematerialisation requests were confirmed to depositories during the reporting period.
• Dematerialised securities were listed on the relevant stock exchanges.
• Physical certificates for dematerialisation were mutilated and cancelled after verification; depository name substituted as owner within prescribed timeline.

Business overview

• Transpek manufactures chlorinated chemicals for polymers, pharma, specialty chemicals, agrochemicals, dyes, and surfactants.
• It operates multipurpose plants in Vadodara and Ekalbara, with 66,000 MTPA capacity.

Operational highlights

• FY26 saw new acid chloride products introduced in small volumes.
• The company expanded into Eurasia and South America and added domestic products.
• It manages over 600 ISO tanks and emphasizes in-house R&D and process safety.

Financial performance

• FY26 revenue was Rs. 645.7 crore, down 4.8% year-on-year.
• FY26 EBITDA was Rs. 117.9 crore, with 18.3% margin.
• FY26 PAT was Rs. 45.6 crore, down 6.3% year-on-year; PAT margin was 7.1%.
• Q4 FY26 revenue fell 11.9% year-on-year to Rs. 152.5 crore.
• Q4 FY26 EBITDA was Rs. 22.0 crore, with 14.4% margin; PAT was Rs. 6.6 crore.
• International sales were 83.1% of FY26 revenue; North America was the largest region at 62.9%.

Capital structure

• Total equity rose to Rs. 767.4 crore at March 2026 from Rs. 745.3 crore.
• Total borrowings were Rs. 42.5 crore at March 2026, versus Rs. 36.9 crore a year earlier.
• Cash and cash equivalents were Rs. 57.8 crore, with bank balances of Rs. 57.3 crore.
• The board recommended a dividend of Rs. 20 per share for FY26, subject to approval.

Outlook

• Management remains cautious due to geopolitical uncertainty and weak western demand.
• Growth is expected from new product commercialization in 2026-2027.
• The company is expanding non-acid and non-alkyl chloride chemistries and new geographies.
• Focus areas include energy efficiency, cost optimization, and sustainable manufacturing.

Risks

• FY26 performance was hurt by subdued demand, crude oil volatility, and weaker western markets.
• Management flagged West Asia conflict as a potential demand and supply risk.

Governance

• Alak D. Vyas signed the filing as Company Secretary and Compliance Officer.
• The presentation lists Ashwin C. Shroff as Chairman and Bimal Mehta as Managing Director.